A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery
Transfusion · 2025
DOI: 10.1111/trf.18281 ↗Kurz gefasst
Äquivalenzstudie in der Zeitschrift Transfusion, 2025. Verfasst von Magali J Fontaine und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Platelet Transfusion, Cardiac Surgical Procedures, Blood Platelets, Platelet Function Tests. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, U.S. Food and Drug Administration, NIH HHS.
Abstract (Originalsprache)
Background
Cardiac surgery on cardiopulmonary bypass (CPB) may alter platelet (PLT) function causing bleeding. The goal of this study is to evaluate the hemostatic effect of PRT‐PLTs compared to untreated PLTs stored in platelet additive solution (PAS) following transfusion in bleeding patients undergoing cardiac surgery on CPB.
Methods
In this single‐center, prospective single‐blinded two‐arm noninferiority trial, patients being weaned off CPB were allocated to either a PRT‐PLT or a standard PAS‐PLT. The primary outcome was the change in maximum amplitude (ΔMA) on thromboelastographic testing (TEG) from pre‐ to post‐transfusion. The non‐inferiority margin was chosen as 50% of the ΔMA observed with PAS‐PLT using a 1‐sided 95% confidence interval. The secondary outcomes included the volume of chest tube drainage (CTD) and the number of blood products transfused during the first 24 h post‐surgery.
Results
A modified intention‐to‐treat analysis included 90 patients (48 PRT ‐ PLTs ; 42 PAS ‐ PLTs ). The ΔMA for PRT ‐ PLT was 2.93 mm (95% CI 1.52–4.34) and was lower than that achieved with PAS ‐ PLT at 5.68 mm (95% CI 3.26–8.09) (2‐tailed p = .052). The ratio of ΔMA for PRT ‐ PLT relative to PAS ‐ PLT was estimated at .52 with a 90% confidence interval (.29, .89) and did not meet the non‐inferiority criterion (>.5). The CTD and the number of blood products transfused during the first 24 h post‐surgery were similar in both arms.
Conclusion
PRT‐PLT transfusion results in lower responses in viscoelastic testing compared to PAS‐PLT, although clinical outcomes with respect to blood component utilization and chest tube drainage were similar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Anesthesia, University of Oklahoma Health Sciences Center, Oklahoma, Oklahoma, USA.
- Office of Blood Research and Review, Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Silver Spring, Maryland, USA.
- Department of Anesthesia, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Magali J Fontaine, Min Zhan, Kenichi Tanaka, Carlos H Villa, Chintamani D Atreya
Förderung
- NIGMS NIH HHS
- U.S. Food and Drug Administration
- NIH HHS
- National Institutes of Health
Zitieren
APA
Fontaine, M. J., Lasola, J. J. M., Martinez-Hernandez, A., Marshall, J. N., Bentzen, S., Zhan, M., Lokhandwala, P. M., Tanaka, K., Villa, C. H., Jones, A., Atreya, C. D., & Henderson, R. A. (2025). A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery. Transfusion. https://doi.org/10.1111/trf.18281
Vancouver
Fontaine MJ, Lasola JJM, Martinez-Hernandez A, Marshall JN, Bentzen S, Zhan M, et al. A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery. Transfusion. 2025. doi:10.1111/trf.18281
BibTeX
@article{Fontaine2025,
author = {Fontaine, Magali J and Lasola, Jackline J M and Martinez-Hernandez, Aidaelis and Marshall, Juliana N and Bentzen, Soren and Zhan, Min and Lokhandwala, Parvez M and Tanaka, Kenichi and Villa, Carlos H and Jones, Alexis and Atreya, Chintamani D and Henderson, Reney A},
title = {A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18281}
}
EUVIMED